Literature DB >> 9416634

Continued inhibitory capacity throughout adulthood: conceptual negative priming in younger and older adults.

C Schooler1, E Neumann, L J Caplan, B R Roberts.   

Abstract

Two negative priming experiments in older and younger adults are reported. Participants in Experiment 1, involving both positive and negative priming conditions, showed both types of priming. There were no significant differences between age groups. If anything, older participants showed more negative priming. In Experiment 2, involving only negative priming conditions, similar results were obtained. Our findings rule out possible effects of experimental conditions that episodic retrieval theorists have suggested might account for negative priming in older adults. Although our results may be consistent with an explanation of negative priming in older adults by an expansively specified theory of episodic retrieval, they are at least as consistent with the view that inhibitory processes are intact in older adults. In light of these findings, conflicting empirical results and alternative views of negative priming in older adults are examined.

Entities:  

Mesh:

Year:  1997        PMID: 9416634     DOI: 10.1037//0882-7974.12.4.667

Source DB:  PubMed          Journal:  Psychol Aging        ISSN: 0882-7974


  3 in total

1.  Cross-language positive priming disappears, negative priming does not: evidence for two sources of selective inhibition.

Authors:  E Neumann; M S McCloskey; A C Felio
Journal:  Mem Cognit       Date:  1999-11

2.  Influence of attended repetition trials on negative priming in younger and older adults.

Authors:  Patricia M Simone; Karen Ahrens; Karin Elaine Goodson Foerde; Michael Spinetta
Journal:  Mem Cognit       Date:  2006-01

3.  Older adults do not notice their names: a new twist to a classic attention task.

Authors:  Moshe Naveh-Benjamin; Angela Kilb; Geoffrey B Maddox; Jenna Thomas; Hope C Fine; Tina Chen; Nelson Cowan
Journal:  J Exp Psychol Learn Mem Cogn       Date:  2014-05-12       Impact factor: 3.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.